240 related articles for article (PubMed ID: 12956285)
1. Mechanisms and clinical relevance of androgens and androgen receptor actions.
Kang HY; Tsai MY; Chang C; Huang KE
Chang Gung Med J; 2003 Jun; 26(6):388-402. PubMed ID: 12956285
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of androgen action--a historical perspective.
Brinkmann AO
Methods Mol Biol; 2011; 776():3-24. PubMed ID: 21796517
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling.
Pihlajamaa P; Sahu B; Jänne OA
Endocr Rev; 2015 Aug; 36(4):357-84. PubMed ID: 26052734
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor (AR) coregulators: an overview.
Heinlein CA; Chang C
Endocr Rev; 2002 Apr; 23(2):175-200. PubMed ID: 11943742
[TBL] [Abstract][Full Text] [Related]
5. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer.
Avila DM; Zoppi S; McPhaul MJ
J Steroid Biochem Mol Biol; 2001; 76(1-5):135-42. PubMed ID: 11384871
[TBL] [Abstract][Full Text] [Related]
6. Androgen action.
Werner R; Holterhus PM
Endocr Dev; 2014; 27():28-40. PubMed ID: 25247642
[TBL] [Abstract][Full Text] [Related]
7. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.
Heinlein CA; Chang C
Mol Endocrinol; 2002 Oct; 16(10):2181-7. PubMed ID: 12351684
[TBL] [Abstract][Full Text] [Related]
8. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
9. [Androgen--biosynthesis, receptor and action].
Shiina H; Igawa M
Nihon Rinsho; 1997 Nov; 55(11):2860-4. PubMed ID: 9396277
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion.
Sathya G; Chang CY; Kazmin D; Cook CE; McDonnell DP
Cancer Res; 2003 Nov; 63(22):8029-36. PubMed ID: 14633736
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor corepressors: an overview.
Wang L; Hsu CL; Chang C
Prostate; 2005 May; 63(2):117-30. PubMed ID: 15486994
[TBL] [Abstract][Full Text] [Related]
12. The androgen receptor in health and disease.
Matsumoto T; Sakari M; Okada M; Yokoyama A; Takahashi S; Kouzmenko A; Kato S
Annu Rev Physiol; 2013; 75():201-24. PubMed ID: 23157556
[TBL] [Abstract][Full Text] [Related]
13. The biological and clinical advances of androgen receptor function in age-related diseases and cancer [Review].
Takayama KI
Endocr J; 2017 Oct; 64(10):933-946. PubMed ID: 28824023
[TBL] [Abstract][Full Text] [Related]
14. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of androgen action.
Lindzey J; Kumar MV; Grossman M; Young C; Tindall DJ
Vitam Horm; 1994; 49():383-432. PubMed ID: 7810074
[TBL] [Abstract][Full Text] [Related]
16. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
[TBL] [Abstract][Full Text] [Related]
17. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.
Ricke EA; Williams K; Lee YF; Couto S; Wang Y; Hayward SW; Cunha GR; Ricke WA
Carcinogenesis; 2012 Jul; 33(7):1391-8. PubMed ID: 22535887
[TBL] [Abstract][Full Text] [Related]
18. [The androgen receptor: molecular pathology].
Sultan Ch; Gobinet J; Terouanne B; Paris F; Belon Ch; Jalaguier S; Georget V; Poujol N; Auzou G; Lumbroso S
J Soc Biol; 2002; 196(3):223-40. PubMed ID: 12465595
[TBL] [Abstract][Full Text] [Related]
19. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor in prostate cancer.
Heinlein CA; Chang C
Endocr Rev; 2004 Apr; 25(2):276-308. PubMed ID: 15082523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
